Wellbutrin Lawsuit
“Nationwide representation: No attorney’s fees unless we win.”
What is the basis of the Wellbutrin lawsuit?
The Wellbutrin lawsuit is based upon scientific evidence linking Wellbutrin use during pregnancy with certain serious birth defects, including heart defects. The Wellbutrin lawsuit alleges that the drug company failued to adequately warn pregnant women and doctors about the serious risks of Wellbutrin use during pregnancy. The Wellbutrin lawsuit seeks monetary compensation for the children who were born with birth defects as a result of Wellbutrin use.
Who can join the Wellbutrin lawsuit?
If you took Wellbutrin during pregnancy and your baby was born with birth defects, you should contact our office immediately for a free confidential case evaluation. Attorneys in our office are available to discuss your case and if you qualify will agree to investigate your case under an agreement whereby you pay no attorney’s fees unless we obtain a settlement or verdict on your behalf.
Wellbutrin, Wellbutrin SR, wellbutrin XL, Aplenzin and Zyban are all pharmaceutical brand names of bupropion pills manufactured and sold by pharmaceutical giant GlaxoSmithKline.
Wellbutrin is a common antidepressant indicated for treatment of bipolar seasonal affective disorder. Its main ingredient is bupropion which is a dopamine indicated for treatment of clinical depression. It is also used to treat anxiety and social phobia that comes with depression.
Wellbutrin has also been shown to be effective in reducing the severity and symptoms of nicotine cravings. Combined with other medications, the pill has also been shown to be effective in the treatment of obesity.
Some success has also been shown in reducing the symptoms of ADDH or attention deficit hyper activity disorder. It has also been shown to be quite effective in the treatment of neuropathic pain.
Despite the apparent benefits, there is evidence linking Wellbutrin to birth defects when used during pregnancy. A report published by the American Journal of Obstetrics and Gynaecology found that bupropion, the main ingredient in Wellbuprin is associated with the risk of cardiac birth defects.
The report released in July after comprehensive studies found that pregnant mothers who used Wellbutrin within the first trimester ran a greater risk of having a child born with heart defects.
These Wellbutrin birth defects include:
Heart ventricle outflow track defects
Ventricular septal defects
PPHN (persistent pulmonary hypertension in newborn)
Atrial septal defect
These conditions have been linked to taking Wellburin or some of its derivatives during the first few months of pregnancy. The adverse side effects of the drug were however kept under wraps by the company. This has prompted the Welbutrin birth defect lawsuit to be filed against the company for not properly explaining the drugs reaction.
With over forty thousand babies born with congenital heart defects every year, the case against wellbutrin birth defects is a strong one. There has been a connection between congenital birth defects and ingestion of teratogenic drugs during pregnancy. These are pharmaceutical drugs or other substances capable of interfering with the development of a foetus and ultimately causing serious birth defects.
Bupropion is a mild teratogenic substance and two in a thousand births by mothers on wellbutrin therapy run the risk of giving birth to babies with heart deformities.